NVZMY Stock - Novozymes A/S
Unlock GoAI Insights for NVZMY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.83B | $17.90B | $17.55B | $14.95B | $14.01B |
| Gross Profit | $1.81B | $9.72B | $9.58B | $8.62B | $7.85B |
| Gross Margin | 47.2% | 54.3% | 54.6% | 57.7% | 56.0% |
| Operating Income | $659.00M | $3.98B | $4.63B | $4.01B | $3.65B |
| Net Income | $305.80M | $3.02B | $3.68B | $3.15B | $2.83B |
| Net Margin | 8.0% | 16.9% | 20.9% | 21.0% | 20.2% |
| EPS | $1.10 | $1.46 | $13.29 | $11.32 | $10.07 |
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Visit WebsiteEarnings History & Surprises
NVZMYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q3 2025 | Aug 21, 2025 | $0.67 | $0.05 | -93.2% | ✗ MISS |
Q2 2025 | May 8, 2025 | $0.44 | $0.06 | -86.5% | ✗ MISS |
Q1 2025 | Feb 27, 2025 | $1.10 | $0.07 | -93.3% | ✗ MISS |
Q4 2024 | Nov 28, 2024 | $0.57 | $0.48 | -16.7% | ✗ MISS |
Q3 2024 | Aug 28, 2024 | $0.71 | $0.12 | -82.7% | ✗ MISS |
Q2 2024 | May 29, 2024 | $0.56 | $0.12 | -78.0% | ✗ MISS |
Q1 2024 | Feb 1, 2024 | $0.47 | $0.36 | -23.4% | ✗ MISS |
Q4 2023 | Oct 26, 2023 | $0.42 | $0.49 | +16.7% | ✓ BEAT |
Q3 2023 | Aug 9, 2023 | $0.42 | $0.32 | -23.8% | ✗ MISS |
Q2 2023 | Apr 26, 2023 | $2.99 | $2.82 | -5.7% | ✗ MISS |
Q1 2023 | Jan 26, 2023 | $0.41 | $0.44 | +7.8% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $0.54 | $0.56 | +3.7% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $0.39 | $0.41 | +5.1% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $0.43 | $0.45 | +4.0% | ✓ BEAT |
Q1 2022 | Feb 1, 2022 | $2.38 | $0.36 | -84.9% | ✗ MISS |
Q4 2021 | Oct 26, 2021 | $2.56 | $0.48 | -81.3% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $0.41 | $0.46 | +12.2% | ✓ BEAT |
Q2 2021 | Apr 27, 2021 | $0.45 | $0.51 | +13.3% | ✓ BEAT |
Q1 2021 | Feb 2, 2021 | $0.42 | $0.37 | -11.9% | ✗ MISS |
Latest News
Frequently Asked Questions about NVZMY
What is NVZMY's current stock price?
What is the analyst price target for NVZMY?
What sector is Novozymes A/S in?
What is NVZMY's market cap?
Does NVZMY pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to NVZMY for comparison